Zantac / Ranitidine (NDMA Cancer) Attorney in Fresno, California

Zantac Litigation in Fresno / Central Valley

Fresno and the Central Valley represent a significant and underserved Zantac claimant population. California's Frye/Kelly standard — applied by Fresno County Superior Court — is more favorable for Zantac causation experts than Daubert. Agricultural workers and food processing industry employees in the Fresno area frequently used OTC ranitidine for occupational GI stress. California's 2-year SOL with the discovery rule and the favorable Kelly standard make California state court a viable primary venue. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Fresno Zantac Claimants

Fresno-area Zantac claimants should gather pharmacy records from Walmart Pharmacy, Rite Aid, Walgreens, CVS, and Raley's pharmacies. UCSF Fresno and Community Medical Centers records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. California's 2-year SOL applies from discovery of the Zantac-NDMA-cancer link — consult qualified plaintiffs' counsel immediately.